Companies / Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

Nasdaq: ACRSCIK 1557746WAYNE, PA

Financials · FY2025

Revenue$7.83M
Net income$-64.92M
Total debt$10.73M
Cash$19.17M
Diluted EPS$-0.53
Shares outstanding147.2M

Ownership

147.2M shares outstanding · as of Jul 31, 2026
1.4%Insiders
Ownership
Insiders1.40%2,056,794
10%+ / strategic30.06%44,245,629
Institutions57.81%85,095,328
Public float10.73%15,801,142

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Leonard Braden Michael10% owner
9.48%13,950,000
Walker NealCEOCEO · Director
1.05%1,543,886
Loerop JamesChief Business Officer
0.13%192,260
Balthaser KevinChief Financial Officer
0.13%187,453
Davis Hugh M.President and COO · Director
0.03%45,425
Gowen MaxineDirector
0.02%33,334
Milano VincentDirector
0.02%28,896
Schiff Andrew NDirector
0.02%25,540
Hall Jesse WayneChief Medical Officer
——
Kolbeck Roland WilhelmChief Scientific Officer
——

Institutional holders 126

View all →
HolderValue% of shares
BML Capital Management, LLC$63.35M8.14%
BlackRock, Inc.$53.10M6.82%
Vivo Capital, LLC$26.76M6.04%
RA Capital Management, L.P.$25.52M4.62%
Vanguard Group Inc$19.57M4.42%
State Street Corporation$17.22M2.21%
Adage Capital Partners Gp, L.L.C.$14.52M2.63%
Rock Springs Capital Management LP$13.41M3.03%
Balyasny Asset Management L.P.$12.60M2.28%
Decheng Capital LLC$12.17M2.75%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 23, 2026Leonard Braden Michael
10% owner
SellCommon Stock$1.36M-300K
-2.11%
13,950,000
9.48% of shares
medium
Dec 31, 2025Loerop James
Executive
OtherCommon Stock$102.3K-34K
-19.20%
143,062
0.10% of shares
low
Feb 3, 2026Walker Neal
CEO
OtherCommon Stock$64.6K-19K
-1.19%
1,543,886
1.05% of shares
low
Dec 31, 2025Balthaser Kevin
Executive
OtherCommon Stock$60.0K-20K
-11.98%
146,424
0.10% of shares
low
Feb 1, 2025Loerop James
Executive
OtherCommon Stock$39.6K-16K
-13.46%
102,773
0.07% of shares
low
Feb 1, 2025Loerop James
Executive
OtherCommon Stock$39.6K-16K
-13.46%
102,773
0.07% of shares
low
Feb 1, 2026Loerop James
Executive
OtherCommon Stock$37.5K-11K
-5.68%
177,322
0.12% of shares
low
Jan 2, 2026Walker Neal
CEO
OtherCommon Stock$28.7K-10K
-0.66%
1,499,022
1.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
BML Investment Partners, L.P.Passive13G/A—14,250,000—
Biosion, Inc.Passive13G/A———
BlackRock, Inc.Passive13G/A—6,700,629—
Deep Track Capital, LPPassive13G—9,345,000—
RA Capital Management, L.P.Passive13G———
BML Investment Partners, L.P.Passive13G/A—13,950,000—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ACRS——00461U105—